Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
Codullo V, Iannone F, Sinigaglia L, Favalli EG, Sarzi-Puttini P, Atzeni F, Ferraccioli G, Gremese E, Carletto A, Giollo A, Govoni M, Bergossi F, Galeazzi M, Cantarini L, Salaffi F, Di Carlo M, Bazzani C, Pellerito R, Sebastiani M, Ramonda R, Lapadula G, Caporali R.
Codullo V, et al. Among authors: atzeni f.
Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.
Clin Exp Rheumatol. 2017.
PMID: 28516879